KVP Capital Advisors »

Erasca shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Erasca (ERAS) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.5M 340k 16.18

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Aadi Bioscience (WHWK)
Axsome Therapeutics (AXSM)
Sutro Biopharma Com Shs (STRO)
Protagonist Therapeutics (PTGX)
Erasca (ERAS)
Trevi Therapeutics (TRVI)
Tango Therapeutics (TNGX)
Insmed Com Par $.01 (INSM)
Edgewise Therapeutics (EWTX)
Revolution Medicines (RVMD)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)

View all positions for KVP Capital Advisors

Top funds holding Erasca

Frazier Life Sciences Management
BlackRock
VR Adviser
T. Rowe Price Investment Management
Vanguard Group
Vivo Capital
Vanguard Capital Management
Logos Global Management
Paradigm Biocapital Advisors
Siren
Arch Venture Corp
State Street Corporation
Geode Capital Management
Cormorant Asset Management
Balyasny Asset Management

View all funds holding Erasca